394 related articles for article (PubMed ID: 33220027)
1. The Role of Salivary Pepsin in the Diagnosis of Gastroesophageal Reflux Disease (GERD) Evaluated Using High-Resolution Manometry and 24-Hour Multichannel Intraluminal Impedance-pH Monitoring.
Guo Z; Wu Y; Chen J; Zhang S; Zhang C
Med Sci Monit; 2020 Nov; 26():e927381. PubMed ID: 33220027
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of salivary pepsin measurement in patients with proton pump inhibitor-refractory gastroesophageal reflux disease symptoms: a prospective comparative study.
Matsumura T; Arai M; Suzuki T; Hoppo T; Seki Y; Kasamatsu S; Ishigami H; Ishikawa K; Okimoto K; Akizue N; Maruoka D; Nakagawa T; Odaka T; Okamoto Y; Kato N
Esophagus; 2020 Jul; 17(3):339-347. PubMed ID: 31982992
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic value of pepsin detection in saliva for gastro-esophageal reflux disease: a preliminary study from China.
Du X; Wang F; Hu Z; Wu J; Wang Z; Yan C; Zhang C; Tang J
BMC Gastroenterol; 2017 Oct; 17(1):107. PubMed ID: 29041918
[TBL] [Abstract][Full Text] [Related]
4. Salivary Pepsin Lacks Sensitivity as a Diagnostic Tool to Evaluate Extraesophageal Reflux Disease.
Dy F; Amirault J; Mitchell PD; Rosen R
J Pediatr; 2016 Oct; 177():53-58. PubMed ID: 27453366
[TBL] [Abstract][Full Text] [Related]
5. Gastroesophageal reflux disease and salivary pepsin in patients with heterotopic gastric mucosa in the upper esophagus.
Xiong X; He S; Xu F; Xu Z; Zhang X; Wang H; Liu T; Jia Y
Dis Esophagus; 2022 Apr; 35(4):. PubMed ID: 34750620
[TBL] [Abstract][Full Text] [Related]
6. The clinical application value of salivary pepsin in the diagnosis of gastroesophageal reflux diseases.
Chen R; Shi L; Huang X; Mao H; Feng B; Wang M; Lin L; Jiang L
Neurogastroenterol Motil; 2023 Sep; 35(9):e14627. PubMed ID: 37332241
[TBL] [Abstract][Full Text] [Related]
7. Pepsin in saliva as a biomarker for oropharyngeal reflux compared with 24-hour esophageal impedance/pH monitoring in pediatric patients.
Fortunato JE; D'Agostino RB; Lively MO
Neurogastroenterol Motil; 2017 Feb; 29(2):. PubMed ID: 27604397
[TBL] [Abstract][Full Text] [Related]
8. Combined Multichannel Intraluminal Impedance and pH Measurement in Detecting Gastroesophageal Reflux Disease in Children.
Safe M; Cho J; Krishnan U
J Pediatr Gastroenterol Nutr; 2016 Nov; 63(5):e98-e106. PubMed ID: 27574881
[TBL] [Abstract][Full Text] [Related]
9. Mean nocturnal baseline impedance: Influencing factors and diagnostic value in gastroesophageal reflux disease.
Wang N; Guo ZH; Wu YH; Zhang C
Technol Health Care; 2023; 31(5):1875-1886. PubMed ID: 36970927
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Gastroesophageal Reflux by Combined Multichannel Intraluminal Impedance and pH Monitoring and Esophageal Motility Patterns in Children with Esophageal Atresia.
Tong S; Mallitt KA; Krishnan U
Eur J Pediatr Surg; 2016 Aug; 26(4):322-31. PubMed ID: 26445355
[TBL] [Abstract][Full Text] [Related]
11. Persistent Postprandial Regurgitation vs Rumination in Patients With Refractory Gastroesophageal Reflux Disease Symptoms: Identification of a Distinct Rumination Pattern Using Ambulatory Impedance-pH Monitoring.
Nakagawa K; Sawada A; Hoshikawa Y; Nikaki K; Sonmez S; Woodland P; Yazaki E; Sifrim D
Am J Gastroenterol; 2019 Aug; 114(8):1248-1255. PubMed ID: 31246694
[TBL] [Abstract][Full Text] [Related]
12. Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD.
Tolone S; de Cassan C; de Bortoli N; Roman S; Galeazzi F; Salvador R; Marabotto E; Furnari M; Zentilin P; Marchi S; Bardini R; Sturniolo GC; Savarino V; Savarino E
Neurogastroenterol Motil; 2015 Aug; 27(8):1175-82. PubMed ID: 26010058
[TBL] [Abstract][Full Text] [Related]
13. Analysis of contractile segment impedance during straight leg raise maneuver using high-resolution impedance manometry increases diagnostic yield in reflux disease.
Wong MW; Liu TT; Yi CH; Lei WY; Hung JS; Omari T; Cock C; Liang SW; Gyawali CP; Chen CL
Neurogastroenterol Motil; 2022 Jan; 34(1):e14135. PubMed ID: 33772944
[TBL] [Abstract][Full Text] [Related]
14. Combined esophageal multichannel intraluminal impedance and pH monitoring (MII -pH) in the diagnostics and treatment of gastroesophageal reflux disease and its complications.
Masiak W; Wallner G; Wallner J; Pedowski T; Solecki M
Pol Przegl Chir; 2011 Sep; 83(9):488-96. PubMed ID: 22166737
[TBL] [Abstract][Full Text] [Related]
15. Correlation between gastroesophageal flap valve abnormality and novel parameters in patients with gastroesophageal reflux disease symptoms by the lyon consensus.
Guo Z; Wu Y; Zhan Y; Zhang C
Sci Rep; 2021 Jul; 11(1):15076. PubMed ID: 34301972
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of salivary pepsin detection in diagnosing gastroesophageal reflux disease subtypes.
Zhang M; Wu T; Tan N; Chen S; Zhuang Q; Luo Y; Xiao Y
Gastroenterol Rep (Oxf); 2023; 11():goad053. PubMed ID: 37720194
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic thresholds and optimal collection protocol of salivary pepsin for gastroesophageal reflux disease.
Ma SD; Patel VG; Greytak M; Rubin JE; Kaizer AM; Yadlapati RH
Dis Esophagus; 2023 Mar; 36(4):. PubMed ID: 36148576
[TBL] [Abstract][Full Text] [Related]
18. Baseline impedance measured during high-resolution esophageal impedance manometry reliably discriminates GERD patients.
Ravi K; Geno DM; Vela MF; Crowell MD; Katzka DA
Neurogastroenterol Motil; 2017 May; 29(5):. PubMed ID: 27778419
[TBL] [Abstract][Full Text] [Related]
19. Twice-daily proton pump inhibitor therapy does not decrease the frequency of reflux episodes during nocturnal recumbency in patients with refractory GERD: analysis of 200 patients using multichannel intraluminal impedance-pH testing.
Clayton SB; Rife CC; Singh ER; Kalbfleisch JH; Castell DO
Dis Esophagus; 2012; 25(8):682-6. PubMed ID: 22292567
[TBL] [Abstract][Full Text] [Related]
20. Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus.
Ribolsi M; Frazzoni M; Marabotto E; De Carlo G; Ziola S; Maniero D; Balestrieri P; Cicala M; Savarino E
Aliment Pharmacol Ther; 2021 Aug; 54(4):412-418. PubMed ID: 34181753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
